Phosphodiesterase 2 inhibition preferentially promotes NO/guanylyl cyclase/cGMP signaling to reverse the development of heart failure

Autor:	Baliga, Reshma S., Preedy, Michael E. J., Dukinfield, Matthew S., Chu, Sandy M., Aubdool, Aisah A., Bubb, Kristen J., Moyes, Amie J., Tones, Michael A., Hobbs, Adrian J.
Zdroj:	Proceedings of the National Academy of Sciences of the United States of America, 2018 Jul . 115(31), E7428-E7437.
Databáze:	JSTOR Journals
Externí odkaz:	https://www.jstor.org/stable/26529399 Zobrazit plný text záznamu